Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Feb 13 04:00PM ET
8.52
Dollar change
+0.97
Percentage change
12.85
%
IndexRUT P/E- EPS (ttm)-1.08 Insider Own3.28% Shs Outstand147.77M Perf Week6.37%
Market Cap1.26B Forward P/E- EPS next Y-0.70 Insider Trans-0.56% Shs Float142.73M Perf Month40.36%
Income-159.49M PEG- EPS next Q-0.29 Inst Own93.05% Short Float5.98% Perf Quarter31.28%
Sales178.96M P/S7.03 EPS this Y14.70% Inst Trans-20.44% Short Ratio6.09 Perf Half Y86.84%
Book/sh1.37 P/B6.22 EPS next Y23.71% ROA-26.57% Short Interest8.53M Perf Year117.35%
Cash/sh1.51 P/C5.66 EPS next 5Y27.30% ROE-62.44% 52W Range2.28 - 8.33 Perf YTD42.12%
Dividend Est.- P/FCF- EPS past 5Y-1.51% ROI-56.63% 52W High2.28% Beta1.55
Dividend TTM- Quick Ratio2.81 Sales past 5Y22.29% Gross Margin55.02% 52W Low273.68% ATR (14)0.63
Dividend Ex-Date- Current Ratio2.89 EPS Y/Y TTM30.45% Oper. Margin-86.32% RSI (14)63.63 Volatility9.48% 8.63%
Employees709 Debt/Eq0.44 Sales Y/Y TTM5.10% Profit Margin-89.12% Recom1.50 Target Price9.00
Option/ShortYes / Yes LT Debt/Eq0.39 EPS Q/Q52.38% Payout- Rel Volume1.47 Prev Close7.55
Sales Surprise3.06% EPS Surprise10.26% Sales Q/Q3.66% EarningsFeb 11 AMC Avg Volume1.40M Price8.52
SMA2010.15% SMA5022.55% SMA20071.61% Trades Volume2,062,287 Change12.85%
Date Action Analyst Rating Change Price Target Change
Jul-05-23Resumed JP Morgan Overweight $15
Jan-05-23Initiated Scotiabank Sector Outperform $15
Dec-21-22Upgrade Piper Sandler Neutral → Overweight $7.50 → $14
Aug-25-22Initiated Credit Suisse Underperform $8
Jun-03-22Initiated Piper Sandler Neutral $7.50
Feb-16-22Reiterated JP Morgan Overweight $75 → $50
Feb-16-22Reiterated Goldman Neutral $54 → $21
Feb-16-22Reiterated BTIG Research Buy $35 → $30
Feb-16-22Reiterated BofA Securities Buy $40 → $32
Oct-15-21Resumed Cowen Outperform
Feb-12-25 12:00PM
09:56AM
09:40AM
02:11AM
Feb-11-25 06:30PM
05:35PM Loading…
05:35PM
04:45PM
04:05PM
Feb-10-25 07:19AM
Feb-05-25 04:05PM
Feb-04-25 10:28AM
Jan-23-25 05:06PM
06:21AM
Jan-22-25 04:05PM
Jan-17-25 09:40AM
08:33AM Loading…
Jan-16-25 08:33AM
Jan-15-25 10:10AM
Jan-14-25 07:30AM
Jan-07-25 07:30AM
Jan-02-25 04:05PM
Dec-09-24 09:53AM
Dec-07-24 06:30PM
Dec-05-24 07:16AM
Dec-03-24 07:30AM
Nov-29-24 09:40AM
Nov-25-24 01:55PM
Nov-15-24 09:55AM
Nov-08-24 10:18AM
02:29AM
Nov-07-24 06:30PM
06:15PM Loading…
06:15PM
05:11PM
04:05PM
07:30AM
Nov-06-24 07:28AM
Oct-09-24 04:05PM
Oct-04-24 04:35AM
Aug-29-24 07:30AM
Aug-22-24 04:03PM
Aug-01-24 07:00PM
06:20PM
05:23PM
04:05PM
Jul-21-24 06:00AM
Jul-15-24 12:00PM
Jul-11-24 04:05PM
May-31-24 07:30AM
May-29-24 04:05PM
May-25-24 08:30AM
May-24-24 09:58AM
May-23-24 06:00AM
May-16-24 02:30PM
May-08-24 06:43PM
12:19PM
03:54AM
May-07-24 07:30PM
05:47PM
05:40PM
04:37PM
04:05PM
Apr-26-24 10:02AM
Apr-17-24 04:05PM
Apr-02-24 04:05PM
Mar-27-24 04:30PM
08:30AM
Mar-11-24 12:01AM
Feb-22-24 04:05PM
Feb-15-24 10:09AM
06:37AM
Feb-14-24 05:16PM
04:43PM
04:05PM
Feb-13-24 02:23AM
Feb-12-24 09:16AM
Jan-29-24 04:05PM
Dec-27-23 04:05PM
Dec-12-23 05:50AM
Dec-11-23 03:30PM
Dec-09-23 08:30AM
Dec-05-23 07:30AM
Nov-10-23 01:52PM
Nov-09-23 04:17PM
04:05PM
Nov-07-23 07:30AM
Nov-02-23 04:05PM
Oct-26-23 10:02AM
Oct-17-23 07:57AM
Sep-27-23 05:14AM
Sep-13-23 07:30AM
Aug-30-23 04:30PM
Aug-28-23 11:53PM
Aug-24-23 10:29AM
Aug-02-23 05:35PM
04:30PM
04:05PM
Jul-29-23 12:12AM
Jul-19-23 08:52AM
Jul-10-23 04:05PM
Jun-24-23 03:19PM
Jun-16-23 05:02PM
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chad RobinsOfficerFeb 13 '25Proposed Sale8.52100,287854,445Feb 13 05:11 PM
PISKEL KYLEChief Financial OfficerNov 18 '24Sale4.982481,235154,330Nov 19 06:45 PM
BOBULSKY SUSANChief Commercial Officer, MRDOct 08 '24Option Exercise1.985,0009,900253,290Oct 10 05:47 PM
Taylor Stacy LSVP and General CounselAug 22 '24Sale4.5026,922121,079139,365Aug 23 04:27 PM
STACY L TAYLOROfficerAug 22 '24Proposed Sale4.5026,922121,079Aug 22 04:18 PM
NEUPERT PETER MDirectorMar 12 '24Option Exercise0.8415,00012,600169,296Mar 13 05:55 PM
PISKEL KYLEPrincipal Accounting OfficerMar 05 '24Sale3.437,72726,504123,318Mar 06 07:43 PM
Taylor Stacy LSVP and General CounselMar 05 '24Sale3.4313,38145,963166,287Mar 06 07:42 PM
LO FRANCISChief People OfficerMar 05 '24Sale3.4314,70050,439253,745Mar 06 07:42 PM
BENZENO SHARONChief Commercial Ofc Imm MedMar 05 '24Sale3.4429,390100,994327,415Mar 06 07:42 PM
RUBINSTEIN JULIEPresidentMar 05 '24Sale3.4739,070135,764472,754Mar 06 07:41 PM
PETERSON TYCHOChief Financial OfficerMar 05 '24Sale3.4415,45653,169531,553Mar 06 07:40 PM
ROBINS CHAD MCEO and ChairmanMar 05 '24Sale3.4348,673167,0072,576,701Mar 06 07:40 PM
BOBULSKY SUSANChief Commercial Officer, MRDMar 05 '24Sale3.4412,99144,629248,290Mar 06 07:39 PM